Clinical TrialID 6651
Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
NCT00221039
Cutaneous T Cell Lymphoma|Mycosis Fungoides
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6651
- Evidence Id
- 6651
- Core Evidence Id
- 6651
- Source Clinical Trial Id
- 6637
- Herb2 Clinical Trial Id
- HBCT006637
- Nct Id
- NCT00221039
- Title
- Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
- Status
- Completed
- Phase
- Phase 4
- Study Result
- No
- Study Condition
- Cutaneous T Cell Lymphoma|Mycosis Fungoides
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Methoxsalen+ECP
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 7
- Outcome Measure
- The primary endpoint will be the overall response based on skin-weighted assessment., The overall skin repsonse will be assessed at 6month and will consist of an experts assessment of the % of skin involvement at baseline and 6 months., 6 months
- Sponsor Collaborator
- M.D. Anderson Cancer Center|Boston Medical Center|University of Pittsburgh|Case Western Reserve University|Vanderbilt University Medical Center|University of Minnesota|Rush University Medical Center|Mallinckrodt
- Funded By
- OTHER
- Location
- Rush-Presbyterian Hospital, Chicago, Illinois, 60612, United States|Boston Medical Center, Boston, Massachusetts, 02118, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|University Hospital of Cleveland/Case Western Reserve University, Cleveland, Ohio, 44106, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States
- Other Id
- ECTCL1
- Start Date
- 2004-04-02
- Primary Completion Date
- 2011-04-05
- Completion Date
- 2011-04-05
- First Posted
- 2005-09-22
- Results First Posted
- Last Update Posted
- 2018-08-17
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00221039
- Title Cn
- Title En
- Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
- Bilingual Status
- semi_complete